Scott L Tarriff

Title: Scott L. Tarriff: Innovator in Medical Treatments

Introduction

Scott L. Tarriff is a notable inventor based in Mahwah, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of conditions responsive to bendamustine. With a total of 3 patents to his name, Tarriff's work focuses on improving patient care through innovative methods.

Latest Patents

One of Tarriff's latest patents involves a method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration. This method addresses the needs of patients who have fluid and/or sodium intake restrictions. The process includes identifying such patients and administering a bendamustine-containing composition in a volume of about 120 ml or less intravenously over a period of about 15 minutes or less. This approach minimizes cardiac and/or renal stress in patients suffering from diseases such as congestive heart failure or renal disease.

Career Highlights

Scott L. Tarriff is currently associated with Eagle Pharmaceuticals, Inc., where he continues to develop innovative medical solutions. His work has been instrumental in advancing treatment protocols that prioritize patient safety and comfort.

Collaborations

Tarriff collaborates with professionals in the field, including his coworker Srikanth Sundaram. Together, they work towards enhancing the efficacy of medical treatments and improving patient outcomes.

Conclusion

Scott L. Tarriff's contributions to medical innovation demonstrate his commitment to improving healthcare. His patents reflect a deep understanding of patient needs and a dedication to advancing treatment methodologies.